Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    LM PAY

    MCap

    EUR24m

    Last close

    EUR37.60

    ▲ 4.00 (11.90%)

    Pan African Resources

    MCap

    GBP3,141m

    Last close

    GBP1.29

    ▲ 10.50 (8.87%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Oxford Cannabinoid Technologies – executive interview

Oxford Cannabinoid Technologies – executive interview

Oxford Cannabinoid Technologies — 1 video in collection

More on this equity

Based in the UK, Oxford Cannabinoid Technologies is focused on advancing cannabinoid medicines for the treatment of pain and other indications. Lead asset OCT461201 is a CB2 selective agonist being investigated for the treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy and visceral pain in irritable bowel syndrome as initial pain indications. These therapies would be an alternative to opioid therapies, which have been limited in distribution in light of the opioid abuse epidemic. New drugs that target the endocannabinoid system may represent an innovative solution to address this need.

In this interview, CEO Clarissa Sowemimo-Coker provides a recap of the company’s efforts and pipeline.

< Previous
Next >

You may also be interested in these:

Healthcare

SynAct Pharma – executive interview

Healthcare

MindMaze Therapeutics – equity proposition
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.